FIELD: chemistry.
SUBSTANCE: claimed compounds show effect on receptor activated by peroxysome proliferate δ (PPARδ). In formula I: [Formula I] , [Formula VII] , [Formula VI] , A is R1 is C1-4alkyl group; R3 groups are different and denote halogen atom or C1-4alkyl group substituted or unsubstituted by halogen; R4 is R5 is hydrogen atom or hydroxyl group; the other radicals are as defined in the invention claim. Also invention refers to methods of compound I obtainment, to intermediary compounds VI, VII and methods of their obtainment, to medicines of diabetes, obesity, atherosclerosis, hyperlipidemia treatment and prevention, containing thiazole derivative of the formula I as active component.
EFFECT: enhanced activity of derivatives.
21 cl, 10 tbl, 102 ex
Title | Year | Author | Number |
---|---|---|---|
ORGANOSELENIUM COMPOUNDS AND THEIR USE | 2005 |
|
RU2371437C2 |
NOVEL ANTHRANILIC ACID DERIVATIVE OR SALT THEREOF | 2005 |
|
RU2394021C2 |
BICYCLIC COMPOUND | 2013 |
|
RU2640416C2 |
DIARYL COMPOUNDS WITH BRIDGE BOND | 2002 |
|
RU2297409C2 |
USING EP4 RECEPTOR LIGANDS IN TREATMENT OF IL-6-MEDIATED DISEASES | 2003 |
|
RU2285527C2 |
CONDENSED BENZAMIDE DERIVATIVE AND INHIBITOR OF VANILLOID RECEPTOR TYPE 1 ACTIVITY (VRI) | 2005 |
|
RU2392278C2 |
INDOLE DERIVATIVE AND ITS USE IN THERAPEUTIC PURPOSES | 2008 |
|
RU2477274C2 |
2-PYRIDONE DERIVATIVES | 2010 |
|
RU2551847C2 |
THERAPY OF DUCHENNE MUSCULAR DYSTROPHY | 2007 |
|
RU2462458C2 |
BENZIMIDAZOLE DERIVATIVES, BASED PHARMACEUTICAL COMPOSITION AND METHODS OF USING THEM | 2008 |
|
RU2456276C2 |
Authors
Dates
2010-06-20—Published
2006-02-24—Filed